Annual report pursuant to Section 13 and 15(d)

Income Taxes and Tax Receivable Agreement - Additional Information (Details)

v3.22.0.1
Income Taxes and Tax Receivable Agreement - Additional Information (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2018
Valuation Allowance [Line Items]    
Federal operating loss carryforwards $ 109,182  
State net operating loss carryforwards 109,560  
Federal net operating loss not expire   $ 95,896
Foreign tax credit $ 137  
Percentage of benefits expected to realize from tax benefits 15.00%  
Payment obligation basis spread on interest rate 100.00%  
Valuation allowance for deferred tax assets $ 61,592  
Cares act deferred payroll taxes $ 325  
Income tax return examination description The Company’s tax returns remain open for examination in the U.S for years 2018 through 2021.  
Deferred tax assets cumulative loss period 3 years  
Federal net operating losses taxable income limitation 80.00%  
Foreign tax credits expiration date Dec. 31, 2030  
Federal and state net operating loss carryforward expiration date Dec. 31, 2034  
Percentage of ownership change as defined by Section 382 0.50  
Foreign subsidiaries tax examination period in which tax obligation originated 3 years  
Current portion of the TRA liability $ 1,440  
Unrecorded TRA liability $ 37,203  
XPO Holdings    
Valuation Allowance [Line Items]    
Economic interest in subsidiary 51.00%  
Deferred tax assets valuation allowance to equity investment $ 60,197